Immunome, Inc.
🏢 View company profile →9Patents
9Active
9Granted
57Portfolio score
Filing activity: Sep 27, 2019 → Aug 30, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12186403B2 | Immunoconjugates and methods | Chemistry; Metallurgy | 0 | Active |
| US12281085B2 | Bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof | Human Necessities | 0 | Active |
| US12274754B2 | Immunoconjugates and methods | Chemistry; Metallurgy | 0 | Active |
| US12285492B2 | Immunoconjugates and methods | Chemistry; Metallurgy | 0 | Active |
| US11834493B2 | Antibody cocktail against SARS-CoV-2 spike protein | Chemistry; Metallurgy | 0 | Active |
| US12280121B2 | Immunoconjugates and methods | Chemistry; Metallurgy | 0 | Active |
| US12233072B2 | Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds for treating Adenoid Cystic Carcinoma | Chemistry; Metallurgy | 0 | Active |
| US12268750B2 | Immunoconjugates and methods | Chemistry; Metallurgy | 0 | Active |
| US12162945B2 | EPHA2 antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.